Simultaneous deprehensio pro TB infectio et MDR, TB

Tuberculosis (TB), quamvis preventable et sanabile, manet a global salutem periculum. An Aestimari 10.6 million populus ceciderunt ill cum TB in MMXXII, unde in aestimatur 1,3 decies Mortibus terrarum, longe a MMXXV milestone de fine TB belli per qui. Praeterea, anti-TB medicamento resistentia, praecipue MDR-TB (resistens RIF & inh), quod magis provocantes global TB curatio et praeventionis.

Efficient et accurate TB et anti-tb medicamento resistentia diagnosis est clavis ad victoria TB curatio et praeventionis.

Solution

Marcus & Micro-test estIII-in-I TB deprehensio pro TB infectio / RIF & Nih resistendumDeprehensio ornamentum enables agentibus diagnosis et TB et RIF / Inh in unum deprehensio a cessat curva technology.

III-in-I TB / MDR-TB deprehensio determinandum TB infectio et key primam linea medicamentis (RIF / inh) resistentia enables et accurate TB curatio.

Mycobacterium nucleic acidum et rifampicin, isoniazid resistentia deprehensio ornamentum (liquefactio curva)

Vel successfully realizes triplici TB testing (TB infectio, RIF & NIH resistentia) in unum deprehendatur!

Celeri effectus:Available in 2-2.5 hrs cum automatic eventum interpretatio obscuratis technica disciplina operationem;

Test Sample:Sputum, LJ Medium, MGIT medium, bronchial lavagium fluidum;

High sensibility:CX Bacteria / ml pro TB, CL bacteria / ML ad RIZ resistentia, CC bacteria / ml ad inh resistentia, ensuring reliable deprehendatur usque ad humilis bacterial onerat.

Tullius peltas:TB, is6110; RIF resistentia, RPOB (DVII ~ DXXXIII); Inh-resistentia, AHPC, Katg CCCXV;

Quality sanatio:Internum imperium ad sample qualitas sanatio ad redigendum falsum negativis;

Lata compatibilitY: Compatibility cum maxime amet PCR systems ad wide Lab accessibility (Slan-96p, biorad cfx96);

Qui guidelines obsequio:Adhaerens ad qui guidelines ad administratione de medicamento repugnans tuberculosis, cursus fideles et relevance in orci usu.